This study focuses on the problem of tuberculosis (TB), the most important opportunistic infection in many HIV risk populations, including the homeless. When a susceptible person inhales a TB bacterium, TB infection is established. Immunocompromised persons like the HIV-infected an progress rapidly from asymptomatic TB infection to active TB disease. Active disease is life-threatening and infectious, spreading bacteria through the air to others. The social conditions of homelessness, such as group shelters, maximize contact between those at risk for HIV and those with active TB disease. We showed recently that 9% of homeless adults in San Francisco are HIV-infected and 32% are TB-infected. In order to reduce the risk of TB infection to HIV-infected persons, the homeless, and the community at large, it is essential to minimize the number of people with active TB disease. A standard way to do this is to block the preogression from TB infection to active TB disease by six months of prophylaxis with isomiazid (TNH). However this TB prevention strategy is not used for the homeless because of poor adherence to the long course of INH therapy. The proposed study consists first of screening homeless and unstably housed adults to identify TB and HIV infected persons, and second of a clinical trial of methods to improve adherence to INH preventive therapy. We will conduct a three-arm randomized controlled trial of methods to give six months of INH therapy to TB-infected homeless persons. We will compare the use of (1) community-recruited """"""""peer health advisors"""""""" and (2) direct cash incentives to (3) usual care provided by the TR clinic. We will determine the extent to which adherence to TB prevention in the trial is predicted by (a) sociodemographic characteristics, (b) regimen knowledge and TB clinical environment, (c) psychological and behavioral factors, and (d) characteristics of the social environment of homelessness. As a result of screening for the trial, we will be able to estimate new infection rates for both HIV and TB in the homeless. We will identify high risk groups for both infections and examine specific socioeconomic and behavioral risk factors. We will examine heterosexual transmission of HIV and the effects of needle exchange use on HIV seroconversion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH054907-03
Application #
2445569
Study Section
Special Emphasis Panel (SRCM (20))
Project Start
1995-07-01
Project End
1999-01-31
Budget Start
1997-07-01
Budget End
1999-01-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Castillo-Mancilla, Jose R; Morrow, Mary; Boum, Yap et al. (2018) Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. J Acquir Immune Defic Syndr 77:507-513
Dunkley, Emma; Ashaba, Scholastic; Burns, Bridget et al. (2018) ""I beg you…breastfeed the baby, things changed"": infant feeding experiences among Ugandan mothers living with HIV in the context of evolving guidelines to prevent postnatal transmission. BMC Public Health 18:188
Mwimanzi, Francis; Toyoda, Mako; Mahiti, Macdonald et al. (2018) Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals. J Virol 92:
Muiru, Anthony N; Bibangambah, Prossy; Hemphill, Linda et al. (2018) Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda. J Acquir Immune Defic Syndr 78:458-464
Rahimi, Asa; Anmole, Gursev; Soto-Nava, Maribel et al. (2017) In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach. J Virol Methods 240:32-41
Gatanaga, Hiroyuki; Brumme, Zabrina L; Adland, Emily et al. (2017) Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection. AIDS 31:1935-1943
Grelotti, David J; Hammer, Gwendolyn P; Dilley, James W et al. (2017) Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trial. AIDS Care 29:273-279
Bebell, Lisa M; Siedner, Mark J; Musinguzi, Nicholas et al. (2017) Trends in one-year cumulative incidence of death between 2005 and 2013 among patients initiating antiretroviral therapy in Uganda. Int J STD AIDS 28:800-807
Lee, Guinevere Q; Bangsberg, David R; Mo, Theresa et al. (2017) Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches. AIDS 31:2345-2354
McCluskey, Suzanne M; Boum 2nd, Yap; Musinguzi, Nicholas et al. (2017) Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr 76:183-187

Showing the most recent 10 out of 218 publications